| Benzyl isothiocyanate–mediated inhibition of histone deacetylase leads to NF-κB turnoff in human pancreatic carcinoma cells S Batra, RP Sahu, PK Kandala, SK Srivastava Molecular cancer therapeutics 9 (6), 1596-1608, 2010 | 101 | 2010 |
| Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling glucose regulatory protein 78 and AMPK PK Kandala, SK Srivastava Oncotarget 3 (4), 435, 2012 | 67 | 2012 |
| Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 … PK Kandala, SK Srivastava BMC medicine 10, 1-18, 2012 | 65 | 2012 |
| Activation of checkpoint kinase 2 by 3, 3′-diindolylmethane is required for causing G2/M cell cycle arrest in human ovarian cancer cells PK Kandala, SK Srivastava Molecular pharmacology 78 (2), 297-309, 2010 | 54 | 2010 |
| Inhibition of EGFR-AKT Axis Results in the Suppression of Ovarian Tumors In Vitro and in Preclinical Mouse Model S Loganathan, PK Kandala, P Gupta, SK Srivastava Public Library of Science 7 (8), e43577, 2012 | 51 | 2012 |
| Blocking epidermal growth factor receptor activation by 3, 3′-diindolylmethane suppresses ovarian tumor growth in vitro and in vivo PK Kandala, SE Wright, SK Srivastava Journal of Pharmacology and Experimental Therapeutics 341 (1), 24-32, 2012 | 51 | 2012 |
| Diindolylmethane-mediated Gli1 protein suppression induces anoikis in ovarian cancer cells in vitro and blocks tumor formation ability in vivo PK Kandala, SK Srivastava Journal of Biological Chemistry 287 (34), 28745-28754, 2012 | 42 | 2012 |
| Regulation of Janus-activated kinase-2 (JAK2) by diindolylmethane in ovarian cancer in vitro and in vivo PK Kandala, SK Srivastava Drug discoveries & therapeutics 6 (2), 94-101, 2012 | 33 | 2012 |
| The role of K-ras gene mutation in TRAIL-induced apoptosis in pancreatic and lung cancer cell lines RP Sahu, S Batra, PK Kandala, TL Brown, SK Srivastava Cancer chemotherapy and pharmacology 67, 481-487, 2011 | 30 | 2011 |
| DIMming ovarian cancer growth P K Kandala, S K Srivastava Current Drug Targets 13 (14), 1869-1875, 2012 | 24 | 2012 |
| Structure–toxicity relationship of phenolic analogs as anti-melanoma agents: An enzyme directed prodrug approach NM Vad, PK Kandala, SK Srivastava, MY Moridani Chemico-biological interactions 183 (3), 462-471, 2010 | 18 | 2010 |
| Critical role of autophagy proteins Beclin 1 and LC3B in deguelin-induced apoptosis in pancreatic tumor cells in vitro and in vivo: A new paradigm SR Boreddy, PK Kandala, KC Pramanik, P Gupta, SK Srivastava Cancer Research 72 (8_Supplement), 2566-2566, 2012 | | 2012 |
| DIM regulates anoikis through sonic hedgehog in ovarian cancer cells PK Kandala, SK Srivastava Cancer Research 72 (8_Supplement), 2567-2567, 2012 | | 2012 |
| Blocking Janus activated kinase-2 activation by DIM suppresses ovarian tumor growth in vitro and in vivo PK Kandala, SK Srivastava Cancer Research 72 (8_Supplement), 2577-2577, 2012 | | 2012 |
| HDAC inhibition reverses EMT through modulation of ZEB1 SR Boreddy, PK Kandala, P Gupta, SK Srivastava Cancer Research 72 (8_Supplement), 2593-2593, 2012 | | 2012 |
| Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 … SK Srivastava, PK Kandala | | 2012 |
| Targeting Critical Signaling Pathways in Ovarian Cancer by Diindolylmethane PK Kandala Texas Tech University Health Sciences Center, 2012 | | 2012 |
| Targeting multiple signaling pathways in ovarian cancer by diindolylmethane PK Kandala | | 2012 |
| Diindolylmethane potentiates the effect of cisplatin in ovarian cancer cells by inhibiting STAT-3 and VEGF PK Kandala, SE Wright, SK Srivastava Cancer Research 71 (8_Supplement), 3535-3535, 2011 | | 2011 |
| Diindolylmethane induces ER stress mediated autophagy in ovarian cancer cells PK Kandala, SK Srivastava Cancer Research 71 (8_Supplement), 3704-3704, 2011 | | 2011 |
